tiprankstipranks
Trending News
More News >
Johnson & Johnson (DE:JNJ)
XETRA:JNJ
Germany Market
Advertisement

Johnson & Johnson (JNJ) Stock Forecast & Price Target

Compare
142 Followers
See the Price Targets and Ratings of:

JNJ Analyst Ratings

Moderate Buy
18Ratings
Moderate Buy
8 Buy
10 Hold
0 Sell
Based on 18 analysts giving stock ratings to
Johnson
& Johnson
in the past 3 months
TipRanks enables you to focus on the analyst rating consensus of all analysts or only the top performers​ in the past 3 months

JNJ Stock 12 Month Forecast

Average Price Target

€150.88
▲(7.37%Upside)
Based on 18 Wall Street analysts offering 12 month price targets for Johnson & Johnson in the last 3 months. The average price target is €150.88 with a high forecast of €162.55 and a low forecast of €136.89. The average price target represents a 7.37% change from the last price of €140.52.
{"navigator":{"disabled":true},"exporting":{"enabled":false},"title":{"text":null},"chart":{"height":200,"style":{"fontFamily":"Roboto Flex","fontWeight":"400","color":"#5d5d5e"},"spacingTop":30,"spacingRight":60,"events":null},"yAxis":{"labels":{"style":{"color":"inherit"},"distance":6,"x":-6,"y":-6,"zIndex":1,"map_label_formatter":{"131":"€131","139":"€139","147":"€147","155":"€155","163":"€163"}},"plotLines":[{"color":"rgba(0,0,0,0)","value":162.5544658,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":-10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-bottom flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#199ca5\">High </span>\n\n  <span style=\"color:#199ca5\">€162.55</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":150.876210757,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":0,"text":"<div  class=\"positionrelative hoverZ3 triangleleft flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#828080\">Average </span>\n\n  <span style=\"color:#828080\">€150.88</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":136.8879712,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-top flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#912767\">Low </span>\n\n  <span style=\"color:#912767\">€136.89</span>\n  </div></div>","useHTML":true}}],"tickPositions":[131,139,147,155,163],"lineColor":"#dddddd","gridLineWidth":1,"gridLineColor":"#dddddd","lineWidth":1,"title":{"text":""}},"plotOptions":{"series":{"states":{"inactive":{"opacity":1}}},"line":{"animation":{"duration":0},"dataLabels":{"allowOverlap":true},"borderWidth":1,"marker":{"enabled":true,"fillColor":"#FFFFFF","radius":3,"lineWidth":2,"symbol":"circle","lineColor":"#828080"}}},"xAxis":{"labels":{"style":{"color":"inherit"},"rotation":0,"map_label_formatter":{"3":"Oct<br/>2024","6":"Jan<br/>2025","9":"Apr<br/>2025","12":"Jul<br/>2025","25":"Jul<br/>2026"}},"tickPositions":[3,6,9,12,25],"plotLines":[{"color":"#dddddd","width":1,"value":12},{"color":"#dddddd","width":1,"value":12}],"lineWidth":0,"gridLineWidth":1,"gridLineColor":"#dddddd","tickLength":0},"legend":{"symbolRadius":0,"symbolPadding":4,"symbolHeight":14,"borderWidth":0,"symbolWidth":14,"align":"left","verticalAlign":"bottom","enabled":false},"tooltip":{"backgroundColor":"rgba(0,0,0,0)","useHTML":true,"borderWidth":0,"borderColor":"rgba(0,0,0,0)","padding":0,"shadow":null,"headerFormat":"","footerFormat":"","pointFormat":"<div class=\"flexccc lineHeight2 bgwhite shadow2 px3 py3 radiismall fonth10_semibold\">\n                <span class=\"colorgray-3 mb4\">{point.date:%b %d ,%Y}</span>\n                <span>Analyst Consensus</span>\n                {point.info}\n          </div>\n           </div>"},"credits":{"enabled":false},"accessibility":{"description":""},"responsive":{"rules":[{"chartOptions":{"chart":{"spacing":[0,0,0,0],"margin":[30,60,40,5]},"xAxis":{"tickPositions":[3,12,25.25]},"yAxis":{"labels":{"enabled":false}},"title":{"text":null},"subtitle":{"text":null}},"condition":{"maxWidth":500}}]},"series":[{"lineWidth":2,"dashStyle":"ShortDash","name":"High","type":"line","color":"#199ca5","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,133.32,135.56880506153846,137.81761012307692,140.06641518461538,142.31522024615384,144.5640253076923,146.81283036923077,149.06163543076923,151.3104404923077,153.55924555384615,155.80805061538462,158.05685567692308,160.30566073846154,{"y":162.5544658,"marker":{"fillColor":"#199ca5","lineColor":"#199ca5","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Average","type":"line","color":"#828080","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,133.32,134.67047775053845,136.0209555010769,137.37143325161537,138.72191100215383,140.0723887526923,141.42286650323075,142.77334425376924,144.1238220043077,145.47429975484616,146.82477750538462,148.17525525592308,149.52573300646154,{"y":150.876210757,"marker":{"fillColor":"#828080","lineColor":"#828080","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Low","type":"line","color":"#912767","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,133.32,133.5944593230769,133.86891864615384,134.14337796923076,134.4178372923077,134.6922966153846,134.96675593846155,135.24121526153846,135.5156745846154,135.7901339076923,136.06459323076925,136.33905255384616,136.6135118769231,{"y":136.8879712,"marker":{"fillColor":"#912767","lineColor":"#912767","enabled":true,"symbol":"circle"}}]},{"type":"line","data":[{"y":132.151,"date":1719792000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 23,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 20, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":142.706,"date":1722470400000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 15,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 15, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":145.401,"date":1725148800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 15,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 17, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":143,"date":1727740800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 15,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 20, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":144.835,"date":1730419200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 16,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 21, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":145.11,"date":1733011200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 13,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 22, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":136.67,"date":1735689600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 14,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 24, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":143.949,"date":1738368000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 13,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 23, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":155.791,"date":1740787200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 14,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 23, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":144.983,"date":1743465600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 19,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 22, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":136.317,"date":1746057600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 24,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 23, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":134.7,"date":1748736000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 25,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 22, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":133.32,"date":1751328000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 23,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 21, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"fillColor":"black","lineColor":"black","enabled":true,"symbol":"circle"}},null,null,null,null,null,null,null,null,null,null,null,null],"color":"#0666a7"}]}
Highest Price Target€162.55Average Price Target€150.88Lowest Price Target€136.89
The highest, average, and lowest price target of all analysts. Click on ‘Top Analysts’ to focus on the best performers.

Detailed List of Analyst Forecasts​

Detailed List of Analyst Forecasts​
Analyst Profile
Expert Firm
Price Target
Position
Upside / Downside
Action
Date
Follow
Article
Leerink Partners Analyst forecast on DE:JNJ
David RisingerLeerink Partners
Leerink Partners
€131.7€147.19
Hold
4.75%
Upside
Reiterated
07/18/25
Balanced Outlook for Johnson & Johnson Amid Growth Prospects and Legal Uncertainties
Barclays Analyst forecast on DE:JNJ
Matt MiksicBarclays
Barclays
€142.03€151.49
Hold
7.81%
Upside
Reiterated
07/17/25
Barclays Remains a Hold on Johnson & Johnson (JNJ)
Bank of America Securities Analyst forecast on DE:JNJ
Tim AndersonBank of America Securities
Bank of America Securities
€138.58€150.63
Hold
7.20%
Upside
Reiterated
07/17/25
Johnson & Johnson: Hold Rating Amid Mixed Signals and Uncertainties
Bernstein Analyst forecast on DE:JNJ
Lee HambrightBernstein
Bernstein
€136.86€148.05
Hold
5.36%
Upside
Reiterated
07/17/25
Johnson & Johnson price target raised to $172 from $159 at BernsteinJohnson & Johnson price target raised to $172 from $159 at Bernstein
UBS
€154.94€163.54
Buy
16.39%
Upside
Reiterated
07/17/25
Johnson & Johnson price target raised to $190 from $180 at UBSJohnson & Johnson price target raised to $190 from $180 at UBS
Morgan Stanley Analyst forecast on DE:JNJ
Terence FlynnMorgan Stanley
Morgan Stanley
€147.19€151.49
Hold
7.81%
Upside
Reiterated
07/17/25
Johnson & Johnson: Balancing Strong Growth Projections with Uncertainties - Hold Rating Maintained
Citi
€159.24
Buy
13.32%
Upside
Assigned
07/16/25
Johnson & Johnson's Strong Financial Performance and Strategic Positioning Justifies Buy Rating
Argus Research Analyst forecast on DE:JNJ
David ToungArgus Research
Argus Research
Buy
Reiterated
07/16/25
Argus Research Sticks to Its Buy Rating for Johnson & Johnson (JNJ)
Wells Fargo Analyst forecast on DE:JNJ
Larry BiegelsenWells Fargo
Wells Fargo
€146.33
Hold
4.13%
Upside
Reiterated
07/16/25
Cautious Optimism: Johnson & Johnson's Strong Performance and Future Prospects Amid Legal Uncertainties
Guggenheim Analyst forecast on DE:JNJ
Vamil DivanGuggenheim
Guggenheim
€141.16€143.75
Hold
2.30%
Upside
Reiterated
07/16/25
Guggenheim Sticks to Its Hold Rating for Johnson & Johnson (JNJ)
TD Cowen
€159.24
Buy
13.32%
Upside
Reiterated
07/16/25
Johnson & Johnson's Strong Q2 Performance and Growth Prospects Earn a Buy Rating
Stifel Nicolaus Analyst forecast on DE:JNJ
Rick WiseStifel Nicolaus
Stifel Nicolaus
€133.42€142.03
Hold
1.07%
Upside
Reiterated
07/16/25
Johnson & Johnson price target raised to $165 from $155 at StifelJohnson & Johnson price target raised to $165 from $155 at Stifel
J.P. Morgan Analyst forecast on DE:JNJ
Chris SchottJ.P. Morgan
J.P. Morgan
€159.24
Hold
13.32%
Upside
Reiterated
07/16/25
Johnson & Johnson: Strong Performance Overshadowed by Biosimilar Competition and Litigation Risks
Goldman Sachs Analyst forecast on DE:JNJ
Asad HaiderGoldman Sachs
Goldman Sachs
€152.35
Buy
8.42%
Upside
Reiterated
07/16/25
Johnson & Johnson's Strong Financial Performance and Strategic Positioning Earns Buy Rating
RBC Capital
€155.8€159.24
Buy
13.32%
Upside
Reiterated
07/16/25
RBC Capital Sticks to Its Buy Rating for Johnson & Johnson (JNJ)
Ranks
Any
Any
Analyst Rating
Any
Any
Upside/ Downside
Any
Any
Action
Any
Any
Analyst Profile
Expert Firm
Price Target
Position
Upside / Downside
Action
Date
Follow
Article
Leerink Partners Analyst forecast on DE:JNJ
David RisingerLeerink Partners
Leerink Partners
€131.7€147.19
Hold
4.75%
Upside
Reiterated
07/18/25
Balanced Outlook for Johnson & Johnson Amid Growth Prospects and Legal Uncertainties
Barclays Analyst forecast on DE:JNJ
Matt MiksicBarclays
Barclays
€142.03€151.49
Hold
7.81%
Upside
Reiterated
07/17/25
Barclays Remains a Hold on Johnson & Johnson (JNJ)
Bank of America Securities Analyst forecast on DE:JNJ
Tim AndersonBank of America Securities
Bank of America Securities
€138.58€150.63
Hold
7.20%
Upside
Reiterated
07/17/25
Johnson & Johnson: Hold Rating Amid Mixed Signals and Uncertainties
Bernstein Analyst forecast on DE:JNJ
Lee HambrightBernstein
Bernstein
€136.86€148.05
Hold
5.36%
Upside
Reiterated
07/17/25
Johnson & Johnson price target raised to $172 from $159 at BernsteinJohnson & Johnson price target raised to $172 from $159 at Bernstein
UBS
€154.94€163.54
Buy
16.39%
Upside
Reiterated
07/17/25
Johnson & Johnson price target raised to $190 from $180 at UBSJohnson & Johnson price target raised to $190 from $180 at UBS
Morgan Stanley Analyst forecast on DE:JNJ
Terence FlynnMorgan Stanley
Morgan Stanley
€147.19€151.49
Hold
7.81%
Upside
Reiterated
07/17/25
Johnson & Johnson: Balancing Strong Growth Projections with Uncertainties - Hold Rating Maintained
Citi
€159.24
Buy
13.32%
Upside
Assigned
07/16/25
Johnson & Johnson's Strong Financial Performance and Strategic Positioning Justifies Buy Rating
Argus Research Analyst forecast on DE:JNJ
David ToungArgus Research
Argus Research
Buy
Reiterated
07/16/25
Argus Research Sticks to Its Buy Rating for Johnson & Johnson (JNJ)
Wells Fargo Analyst forecast on DE:JNJ
Larry BiegelsenWells Fargo
Wells Fargo
€146.33
Hold
4.13%
Upside
Reiterated
07/16/25
Cautious Optimism: Johnson & Johnson's Strong Performance and Future Prospects Amid Legal Uncertainties
Guggenheim Analyst forecast on DE:JNJ
Vamil DivanGuggenheim
Guggenheim
€141.16€143.75
Hold
2.30%
Upside
Reiterated
07/16/25
Guggenheim Sticks to Its Hold Rating for Johnson & Johnson (JNJ)
TD Cowen
€159.24
Buy
13.32%
Upside
Reiterated
07/16/25
Johnson & Johnson's Strong Q2 Performance and Growth Prospects Earn a Buy Rating
Stifel Nicolaus Analyst forecast on DE:JNJ
Rick WiseStifel Nicolaus
Stifel Nicolaus
€133.42€142.03
Hold
1.07%
Upside
Reiterated
07/16/25
Johnson & Johnson price target raised to $165 from $155 at StifelJohnson & Johnson price target raised to $165 from $155 at Stifel
J.P. Morgan Analyst forecast on DE:JNJ
Chris SchottJ.P. Morgan
J.P. Morgan
€159.24
Hold
13.32%
Upside
Reiterated
07/16/25
Johnson & Johnson: Strong Performance Overshadowed by Biosimilar Competition and Litigation Risks
Goldman Sachs Analyst forecast on DE:JNJ
Asad HaiderGoldman Sachs
Goldman Sachs
€152.35
Buy
8.42%
Upside
Reiterated
07/16/25
Johnson & Johnson's Strong Financial Performance and Strategic Positioning Earns Buy Rating
RBC Capital
€155.8€159.24
Buy
13.32%
Upside
Reiterated
07/16/25
RBC Capital Sticks to Its Buy Rating for Johnson & Johnson (JNJ)
Stocks with the Highest Top Analyst Consensus in the Healthcare Sector
Find stocks in the Healthcare sector that are highly recommended by Top Performing Analysts.

Best Analysts Covering Johnson & Johnson

1 Month
xxx
Success Rate
15/25 ratings generated profit
60%
Average Return
+0.96%
reiterated a xxx
rating 6 days ago
Copying xxxxxxxxxxxxxxxxxx
trades and holding each position for 1 Month would result in 60.00% of your transactions generating a profit, with an average return of +0.96% per trade.
3 Months
xxx
Success Rate
22/25 ratings generated profit
88%
Average Return
+3.87%
reiterated a xxx
rating 6 days ago
Copying xxxxxxxxxxxxxxxxxx
trades and holding each position for 3 Months would result in 88.00% of your transactions generating a profit, with an average return of +3.87% per trade.
1 Year
Success Rate
25/25 ratings generated profit
100%
Average Return
+9.04%
reiterated a buy rating 6 days ago
Copying Danielle Antalffy's trades and holding each position for 1 Year would result in 100.00% of your transactions generating a profit, with an average return of +9.04% per trade.
2 Years
xxx
Success Rate
40/44 ratings generated profit
91%
Average Return
+16.73%
reiterated a xxx
rating 3 months ago
Copying xxxxxxxxxxxxxxxxxx
trades and holding each position for 2 Years would result in 90.91% of your transactions generating a profit, with an average return of +16.73% per trade.
The Best Analyst Covering tool allows you to follow the analysts who have the best success rates and average returns on a specific stock. Only analysts that gave a Buy or Sell rating on the stock in the past 12 months are eligible for inclusion in this tool. Follow the analysts of your choice to receive real-time updates when they publish a new rating.

JNJ Analyst Recommendation Trends

Rating
Mar 25
Apr 25
May 25
Jun 25
Jul 25
Strong Buy
0
0
0
0
0
Buy
14
19
24
25
23
Hold
23
22
23
22
21
Sell
0
0
0
0
0
Strong Sell
0
0
0
0
0
total
37
41
47
47
44
In the current month, JNJ has received 23 Buy Ratings, 21 Hold Ratings, and 0 Sell Ratings. JNJ average Analyst price target in the past 3 months is 150.88.
Each month's total comprises the sum of three months' worth of ratings.

JNJ Financial Forecast

JNJ Earnings Forecast

Next quarter’s earnings estimate for JNJ is €2.35 with a range of €2.22 to €2.48. The previous quarter’s EPS was €2.37. JNJ beat its EPS estimate 100.00% of the time in the past 12 months, while its overall industry beat the EPS estimate 58.14% of the time in the same period. In the last calendar year JNJ has Outperformed its overall industry.
Next quarter’s earnings estimate for JNJ is €2.35 with a range of €2.22 to €2.48. The previous quarter’s EPS was €2.37. JNJ beat its EPS estimate 100.00% of the time in the past 12 months, while its overall industry beat the EPS estimate 58.14% of the time in the same period. In the last calendar year JNJ has Outperformed its overall industry.

JNJ Sales Forecast

Next quarter’s sales forecast for JNJ is €20.27B with a range of €19.79B to €20.39B. The previous quarter’s sales results were €20.31B. JNJ beat its sales estimates 100.00% of the time in past 12 months, while its overall industry beat sales estimates 47.52% of the time in the same period. In the last calendar year JNJ has Outperformed its overall industry.
Next quarter’s sales forecast for JNJ is €20.27B with a range of €19.79B to €20.39B. The previous quarter’s sales results were €20.31B. JNJ beat its sales estimates 100.00% of the time in past 12 months, while its overall industry beat sales estimates 47.52% of the time in the same period. In the last calendar year JNJ has Outperformed its overall industry.

JNJ Stock Forecast FAQ

What is DE:JNJ’s average 12-month price target, according to analysts?
Based on analyst ratings, Johnson & Johnson’s 12-month average price target is 150.88.
    What is DE:JNJ’s upside potential, based on the analysts’ average price target?
    Johnson & Johnson has 7.37% upside potential, based on the analysts’ average price target.
      Can I see which stocks the top-ranking analysts are rating?
      Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.
        How can I follow the stock ratings of top Wall Street analysts?
        Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.
          Is Johnson & Johnson a Buy, Sell or Hold?
          Johnson & Johnson has a consensus rating of Moderate Buy, which is based on 8 buy ratings, 10 hold ratings and 0 sell ratings.
            What is Johnson & Johnson’s share price target?
            The average share price target for Johnson & Johnson is 150.88. This is based on 18 Wall Streets Analysts 12-month price targets, issued in the past 3 months.
            The highest analyst share price target is €162.55 ,and the lowest forecast is €136.89. The average share price target represents 7.37% Increase from the current price of €140.52.
              What do analysts say about Johnson & Johnson?
              Johnson & Johnson’s analyst rating consensus is a Moderate Buy. This is based on the ratings of 18 Wall Streets Analysts.
                How can I buy shares of Johnson & Johnson?
                To buy shares of DE:JNJ, you can open a brokerage account. See exclusive account opening deals on our Best Online Brokers page.
                  What am I Missing?
                  Make informed decisions based on Top Analysts' activity
                  Know what industry insiders are buying
                  Get actionable alerts from top Wall Street Analysts
                  Find out before anyone else which stock is going to shoot up
                  Get powerful stock screeners & detailed portfolio analysis